Photo: ODT filesPeople addicted to vapes will soon have help to quit, with Medsafe's approval of New Zealand's first vaping-specific nicotine replacement therapy product. The Asthma and Respiratory Foundation welcomed the move as "an important step in the fight against New Zealand's vaping epidemic". Foundation chief executive Letitia Harding said while the product had been on the market for years for smokers, this new indication recognised that NRT was not just for smokers who wanted to quit, but also for those struggling to quit vaping. "Nicotine dependence from vaping is a real and growing problem - so having clinically validated support to quit is important. "While a cessation product is helpful for those already dependent, it doesn't stop young people from starting in the first place."
